Zalsman G - Search Results

1

Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.

Mekori-Domachevsky E, Guri Y, Yi J, Weisman O, Calkins ME, Tang SX, Gross R, McDonald-McGinn DM, Emanuel BS, Zackai EH, Zalsman G, Weizman A, Gur RC, Gur RE, Gothelf D. Mekori-Domachevsky E, et al. Among authors: zalsman g. Schizophr Res. 2017 Oct;188:42-49. doi: 10.1016/j.schres.2016.12.023. Epub 2016 Dec 29. Schizophr Res. 2017. PMID: 28041919 Free PMC article.

2

Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits.

Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A, Erlich Z, Tyano S, Apter A, Weizman A. Zalsman G, et al. Am J Med Genet. 2001 Apr 8;105(3):239-45. doi: 10.1002/ajmg.1261. Am J Med Genet. 2001. PMID: 11353442

3

Geriatric Depression Scale (GDS-15): a sensitive and convenient instrument for measuring depression in young anorexic patients.

Zalsman G, Weizman A, Carel CA, Aizenberg D. Zalsman G, et al. J Nerv Ment Dis. 2001 May;189(5):338-9. doi: 10.1097/00005053-200105000-00015. J Nerv Ment Dis. 2001. PMID: 11379982 No abstract available.

4

Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients.

Valevski A, Ratzoni G, Sever J, Apter A, Zalsman G, Shiloh R, Weizman A, Tyano S. Valevski A, et al. Among authors: zalsman g. J Adolesc. 2001 Oct;24(5):625-33. doi: 10.1006/jado.2001.0423. J Adolesc. 2001. PMID: 11676509

5

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, Poraz I, Frishman S, Constantini N, Zalsman G, Weizman A, Apter A. Gothelf D, et al. Among authors: zalsman g. Am J Psychiatry. 2002 Jun;159(6):1055-7. doi: 10.1176/appi.ajp.159.6.1055. Am J Psychiatry. 2002. PMID: 12042200 Clinical Trial.

6

Alternation learning in OCD/schizophrenia patients.

Hermesh H, Weizman A, Gur S, Zalsman G, Shiloh R, Zohar J, Gross-Isseroff R. Hermesh H, et al. Among authors: zalsman g. Eur Neuropsychopharmacol. 2003 Mar;13(2):87-91. doi: 10.1016/s0924-977x(02)00128-1. Eur Neuropsychopharmacol. 2003. PMID: 12650951

7

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study.

Zalsman G, Frisch A, Lev-Ran S, Martin A, Michaelovsky E, Bensason D, Gothelf D, Nahshoni E, Tyano S, Weizman A. Zalsman G, et al. Eur Neuropsychopharmacol. 2003 May;13(3):183-5. doi: 10.1016/s0924-977x(03)00006-3. Eur Neuropsychopharmacol. 2003. PMID: 12729944 Clinical Trial.

8

Genetics of suicidal behavior: candidate association genetic approach.

Zalsman G, Frisch A, Apter A, Weizman A. Zalsman G, et al. Isr J Psychiatry Relat Sci. 2002;39(4):252-61. Isr J Psychiatry Relat Sci. 2002. PMID: 12756857 Review.

9

Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder.

Apter A, Horesh N, Gothelf D, Zalsman G, Erlich Z, Soreni N, Weizman A. Apter A, et al. Among authors: zalsman g. J Affect Disord. 2003 Jul;75(2):181-9. doi: 10.1016/s0165-0327(02)00038-1. J Affect Disord. 2003. PMID: 12798258

10

Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.

Zalsman G, Carmon E, Martin A, Bensason D, Weizman A, Tyano S. Zalsman G, et al. J Child Adolesc Psychopharmacol. 2003 Fall;13(3):319-27. doi: 10.1089/104454603322572651. J Child Adolesc Psychopharmacol. 2003. PMID: 14642020 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters